LLYbenzinga

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth

Summary

A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 17, 2024 by benzinga